Therapeutic Potential of Kappa-Opioids Against Cocaine - 1 - Tabular View

Tracking Information

First Received Date ^ICMJE

September 20, 1999

Last Updated Date

June 23, 2005

Start Date ^ICMJE

July 1996

Primary Completion Date

Current Primary Outcome Measures ^ICMJE

Original Primary Outcome Measures ^ICMJE

Change History

Complete list of historical versions of study NCT00000323 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Original Secondary Outcome Measures ^ICMJE

Descriptive Information

Brief Title ^ICMJE

Therapeutic Potential of Kappa-Opioids Against Cocaine - 1

Official Title ^ICMJE

Therapeutic Potential of Kappa-Opioids Against Cocaine

Brief Summary

The purpose of this study is to characterize the effects of enadoline compared to hydromorphone and butorphanol.

Detailed Description

Study Phase

Phase I

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Screening

Condition ^ICMJE

Cocaine-Related Disorders

Intervention ^ICMJE

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Completion Date

December 1998

Primary Completion Date

Eligibility Criteria ^ICMJE

Inclusion Criteria:

opiate experienced, healthy

Exclusion Criteria:

physical dependence on opioids, barbiturates or alcohol

Gender

Both

Ages

21 Years to 50 Years

Accepts Healthy Volunteers

Yes

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

United States

Administrative Information

NCT ID ^ICMJE

NCT00000323

Responsible Party

Study ID Numbers ^ICMJE

NIDA-10753-1, R01-10753-1

Study Sponsor ^ICMJE

National Institute on Drug Abuse (NIDA)

Collaborators ^ICMJE

Investigators ^ICMJE

Principal Investigator:

Sharon Walsh, Ph.D.

Johns Hopkins University

Information Provided By

National Institute on Drug Abuse (NIDA)

Verification Date

May 2004

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP